Drug Trial Radar · NCT06312813
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Feb 27, 2024
Primary completion
Dec 1, 2028
Study completion Dec 1, 2028
Sponsor
- Lead sponsor
- Wright State UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.
Conditions
- Rosacea
Interventions
ImipramineDrug
4% imipramine
AmitriptylineDrug
4% amitriptyline
VehicleDrug
0.1ml propylene glycol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 10 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 60 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 120 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% imipramineTime frame: 24 hours post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 10 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 60 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 120 minutes post-treatment
- Difference in redness of Ultraviolet B induced erythema with 4% amitriptylineTime frame: 24 hours post-treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Wright State Physicians
Fairborn, Ohio · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.